TrialClinical drug investigation2013

Safety, tolerability and pharmacokinetics and pharmacodynamics of inhaled once-daily umeclidinium in healthy adults deficient in CYP2D6 activity: a double-blind, randomized clinical trial.

Anthony Cahn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.